Best Growth Stocks To Buy Now

Robust, high-growth companies such as Whirlpool of India are appealing to investors for many reasons. They bring about a strong upside to your portfolio, and less downside risk as opposed to financially challenged companies. Whether it be a well-known tech stock or a risky small-cap, I believe diversification towards growth can add value to your current holdings. Below I’ve compiled a list of stocks with a bright future ahead.

Whirlpool of India Limited (BSE:500238)

Whirlpool of India Limited manufactures and trades in home appliances under the Whirlpool brand in India. Started in 1960, and currently run by Sunil D’souza, the company provides employment to 1,613 people and with the company’s market cap sitting at INR ₹199.47B, it falls under the large-cap category.

Driven by the positive double-digit sales growth of 35.35% over the next few years, 500238 is expected to deliver an excellent earnings growth of 21.37%. It appears that 500238’s profitability may be sustainable as the fundamental push is top-line expansion rather than unmaintainable cost-cutting activities. This prospective profitability should trickle down to shareholders, with analysts expecting the company to generate a high double-digit return on equity of 22.18%. 500238 ticks the boxes for robust growth generation on all levels of line items, which makes it an appealing stock to dig into deeper. Should you add 500238 to your portfolio? Take a look at its other fundamentals here.

BSE:500238 Future Profit May 9th 18
BSE:500238 Future Profit May 9th 18

Coral Laboratories Limited (BSE:524506)

Coral Laboratories Limited manufactures and sells pharmaceutical formulations in India. Founded in 1997, and currently run by , the company provides employment to 189 people and has a market cap of INR ₹2.02B, putting it in the mid-cap stocks category.

Want to know more about 524506? Have a browse through its key fundamentals here.

BSE:524506 Future Profit May 9th 18
BSE:524506 Future Profit May 9th 18

Granules India Limited (BSE:532482)

Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationally. Established in 1984, and currently lead by Krishna Chigurupati, the company provides employment to 2,322 people and has a market cap of INR ₹25.47B, putting it in the large-cap category.

532482’s projected future profit growth is a robust 30.75%, with an underlying 50.02% growth from its revenues expected over the upcoming years. An affirming signal is when net income increase is supported by top-line growth. Since net income isn’t artificially inflated by one-off initiatives such as cost-cutting, we know this profit growth is more likely to be sustainable. This prospective profitability should trickle down to shareholders, with analysts expecting the company to generate a positive return on equity of 16.77%. 532482’s bullish prospects on both the top and bottom lines make it an interesting stock to invest more time to understand how it can add value to your portfolio. Thinking of investing in 532482? Check out its fundamental factors here.

BSE:532482 Future Profit May 9th 18
BSE:532482 Future Profit May 9th 18

For more financially robust companies with high growth potential to enhance your portfolio, explore this interactive list of fast growing companies.